NO961993D0 - Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor - Google Patents

Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor

Info

Publication number
NO961993D0
NO961993D0 NO961993A NO961993A NO961993D0 NO 961993 D0 NO961993 D0 NO 961993D0 NO 961993 A NO961993 A NO 961993A NO 961993 A NO961993 A NO 961993A NO 961993 D0 NO961993 D0 NO 961993D0
Authority
NO
Norway
Prior art keywords
nitric oxide
inhibitor
donor
oxytocin
treatment
Prior art date
Application number
NO961993A
Other languages
English (en)
Other versions
NO961993L (no
Inventor
Robert E Garfield
Chandra Yallampalli
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO961993D0 publication Critical patent/NO961993D0/no
Publication of NO961993L publication Critical patent/NO961993L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO961993A 1993-11-16 1996-05-15 Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor NO961993L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15249693A 1993-11-16 1993-11-16
PCT/EP1994/003817 WO1995013802A1 (en) 1993-11-16 1994-11-17 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor

Publications (2)

Publication Number Publication Date
NO961993D0 true NO961993D0 (no) 1996-05-15
NO961993L NO961993L (no) 1996-07-12

Family

ID=22543178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961993A NO961993L (no) 1993-11-16 1996-05-15 Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor

Country Status (20)

Country Link
EP (1) EP0730448B1 (no)
JP (1) JP4015185B2 (no)
KR (2) KR100358320B1 (no)
CN (1) CN1108795C (no)
AT (1) ATE212833T1 (no)
AU (2) AU8144594A (no)
BR (1) BR9408067A (no)
CA (1) CA2176721A1 (no)
CZ (1) CZ291475B6 (no)
DE (1) DE69429823T2 (no)
DK (1) DK0730448T3 (no)
ES (1) ES2176307T3 (no)
FI (1) FI962109A (no)
HU (1) HUT74465A (no)
NO (1) NO961993L (no)
NZ (1) NZ276105A (no)
PL (1) PL178174B1 (no)
PT (1) PT730448E (no)
SK (1) SK63396A3 (no)
WO (1) WO1995013802A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811416A (en) * 1994-06-06 1998-09-22 Board Of Regents The University Of Texas System Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate
RU2199346C2 (ru) * 1995-03-14 2003-02-27 Шеринг Аг Применение доноров оксида азота или ингибиторов оксида азота для регулирования раскрытия и растяжения шейки матки
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
US5898038A (en) * 1996-03-19 1999-04-27 Board Of Regents, The University Of Texas System Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
US5910482A (en) * 1996-03-19 1999-06-08 Board Of Regents, The University Of Texas System Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US5906987A (en) * 1997-03-10 1999-05-25 Schering Aktiengesellschaft And Board Of Regents Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
ITMI20002117A1 (it) * 2000-09-29 2002-03-29 Ibsa Inst Biochimique Sa Uso di sodio nitroprussiato in ostetricia e ginecologia
FR2842108B1 (fr) 2002-07-09 2008-05-02 Effik Composes a base d'hormone et de monoxyde d'azote et leur utilisation en obstetrique et en gynecologie
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0151114B1 (ko) * 1992-07-01 1998-10-15 사사이 아키라 (-)-리토드린

Also Published As

Publication number Publication date
AU8144594A (en) 1995-06-06
JPH09505068A (ja) 1997-05-20
DE69429823D1 (de) 2002-03-21
WO1995013802A1 (en) 1995-05-26
CN1108795C (zh) 2003-05-21
PL314465A1 (en) 1996-09-16
KR100358319B1 (ko) 2002-10-25
JP4015185B2 (ja) 2007-11-28
NZ276105A (en) 2001-04-27
SK63396A3 (en) 1997-03-05
KR100358320B1 (ko) 2003-01-24
FI962109A (fi) 1996-07-15
DK0730448T3 (da) 2002-04-22
CZ139096A3 (en) 1996-10-16
HU9601299D0 (en) 1996-07-29
DE69429823T2 (de) 2002-08-22
CA2176721A1 (en) 1995-05-26
PL178174B1 (pl) 2000-03-31
EP0730448B1 (en) 2002-02-06
FI962109A0 (fi) 1996-05-17
PT730448E (pt) 2002-07-31
BR9408067A (pt) 1996-12-24
ATE212833T1 (de) 2002-02-15
CZ291475B6 (cs) 2003-03-12
KR960705560A (ko) 1996-11-08
ES2176307T3 (es) 2002-12-01
AU8086398A (en) 1998-10-22
EP0730448A1 (en) 1996-09-11
HUT74465A (en) 1996-12-30
NO961993L (no) 1996-07-12
AU732532B2 (en) 2001-04-26
CN1135178A (zh) 1996-11-06

Similar Documents

Publication Publication Date Title
NO961993D0 (no) Behandling av livmorkontraksjonsforstyrrelser med et nitrogenoksidsyntasesubstrat og/eller -doner eller en nitrogenoksidinhibitor
JPS531114A (en) Method of insulating skid pipe for reheating furnace of steelmaking mill
ES8206473A1 (es) Procedimiento para la preparacion de derivados de prostaci- clina
IS4555A (is) Notkun köfnunarefnisoxíð gjafa eða köfnunarefnisoxíð lata til að tempra leghálsvíkkun og þenslu
Sammour Prostaglandins (PGS)
GB1488339A (en) Method of making surface active silica
JPS5241937A (en) Inductive heating cooker
Hodgson et al. Protocol for management of unsuccessful pregnancy
CA599739A (en) Heat treating furnace
JPS5247697A (en) Super conductor
IL39109A (en) Isolation and purification of kalli-krein-trypsin inhibitor
Eto et al. On the Gauge of Woolly Knitting (Part 2)
CA600744A (en) Heat treating furnace
CA604042A (en) Removal of clays from ores using heating under reducing conditions
CA600365A (en) Insulating refractory arch
AU245918B2 (en) Open hearth furnaces and methods of operating thesame
CA612022A (en) Art of manufacturing cold water dispersible adhesives
AU254223B2 (en) Prevention and removal of maleic acid deposits
CA600249A (en) Electric heating furnace and method of heating
AU6158660A (en) Open hearth furnaces and methods of operating thesame
AU242338B2 (en) Hot discharging of furnaces
YU311775A (en) Process for the isolation of the pure inhibitor of neutral proteinases
CA23337S (en) Checker brick primarily for blast stoves
AU798861A (en) Prevention and removal of maleic acid deposits
AU254444B2 (en) Process forthe reduction of iron oxide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application